We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

140 hedge funds and large institutions have $569M invested in Intellia Therapeutics in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 24

1.26% less ownership

Funds ownership: 93.33% → 92.06% (-1.3%)

2% less funds holding

Funds holding: 143 → 140 (-3)

15% less capital invested

Capital invested by funds: $669M → $569M (-$100M)

33% less call options, than puts

Call options by funds: $1.12M | Put options by funds: $1.67M

Holders
140
Holders Change
-3
Holders Change %
-2.1%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
46
Reduced
35
Closed
24
Calls
$1.12M
Puts
$1.67M
Net Calls
-$548K
Net Calls Change
+$567K

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$20.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.42M
3
IC
Ikarian Capital
Texas
+$2.49M
4
BlackRock
BlackRock
New York
+$1.98M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$4.09M
2
N
Nuveen
North Carolina
-$4.08M
3
AG
Artal Group
Luxembourg
-$2.93M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.67M
5
3C
361 Capital
Colorado
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
LF
126
Lee Financial
Texas
$2K – – –
GI
127
Gradient Investments
Minnesota
$2K +$2.18K +162 New
AA
128
Advisory Alpha
Michigan
$1.42K – – –
TCM
129
Tradewinds Capital Management
Washington
$1K -$1.51K -112 -53%
BCA
130
Berman Capital Advisors
Georgia
$1K – – –
NFG
131
Next Financial Group
Texas
$1K – – –
SWM
132
Selective Wealth Management
Virginia
$1K – – –
TFA
133
Toth Financial Advisory
Virginia
$1K +$1.35K +100 New
MAM
134
Meeder Asset Management
Ohio
$1K +$1.44K +107 New
ECM
135
Estabrook Capital Management
New York
$171 – – –
AG
136
Artal Group
Luxembourg
– -$2.93M -199,700 Closed
3C
137
361 Capital
Colorado
– -$1.39M -94,772 Closed
OAM
138
Oxford Asset Management
United Kingdom
– -$798K -54,375 Closed
JG
139
Jefferies Group
New York
– -$721K -49,175 Closed
Rafferty Asset Management
140
Rafferty Asset Management
New York
– -$667K -45,492 Closed
Renaissance Technologies
141
Renaissance Technologies
New York
– -$538K -36,700 Closed
GCP
142
GSA Capital Partners
United Kingdom
– -$492K -33,533 Closed
Voloridge Investment Management
143
Voloridge Investment Management
Florida
– -$299K -20,382 Closed
KJHP
144
K.J. Harrison & Partners
Ontario, Canada
– -$265K -18,045 Closed
Millennium Management
145
Millennium Management
New York
– -$248K -16,875 Closed
ProShare Advisors
146
ProShare Advisors
Maryland
– -$232K -15,812 Closed
Arrowstreet Capital
147
Arrowstreet Capital
Massachusetts
– -$214K -14,600 Closed
D.E. Shaw & Co
148
D.E. Shaw & Co
New York
– -$185K -12,625 Closed
SOMRS
149
State of Michigan Retirement System
Michigan
– -$179K -12,222 Closed
I
150
INVST
Indiana
– -$177K -12,047 Closed
3 4 5
6
7

NTLA Hedge Fund Activity: Q1 2020 in Review

140 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q1 2020, worth a combined $569M — down 15% from $669M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of NTLA and 23 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 46 added.

The largest buyer was ARK Investment Management, adding an estimated $20.2M. The largest seller was Morgan Stanley, cutting an estimated $4.09M.

  • 140 institutional investors held Intellia Therapeutics (NTLA) as of Q1 2020, down from 143 in Q4 2019.
  • Funds reported $569M of Intellia Therapeutics stock for Q1 2020, down 15% quarter-over-quarter.
  • 23 funds opened new Intellia Therapeutics positions in Q1 2020 and 24 closed out, a net change of -1 holder.
  • The largest Intellia Therapeutics buyer in Q1 2020 was ARK Investment Management, an estimated $20.2M added.
  • The largest Intellia Therapeutics seller in Q1 2020 was Morgan Stanley, an estimated $4.09M sold.

Based on aggregated 13F filings for Q1 2020.